Form 4: Stryker COO Exercises Options, Sells Shares
Insider Transaction Report
Stryker's President and COO, Spencer S. Stiles, exercised employee stock options and subsequently sold shares to cover tax liabilities.
Summary
- Spencer S. Stiles, President and COO of Stryker Corp (SYK), reported transactions involving the company's common stock.
- On February 3, 2026, Stiles exercised employee stock options to acquire 13,840 shares of common stock at an exercise price of $96.64 per share.
- These options were granted on February 10, 2016, under the Stryker Corporation 2011 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the grant date, and were set to expire on February 9, 2026.
- Immediately following the exercise, Stiles disposed of 7,692 shares of common stock at a price of $368.14 per share, primarily to cover tax liabilities associated with the option exercise.
- After these transactions, Stiles directly beneficially owns 68,982 shares of common stock and indirectly owns 1,670 shares through a 401K plan.
- The derivative securities (employee stock options) beneficially owned by Stiles following the reported transactions are now 0.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. It is a standard executive compensation transaction and does not provide new insights into the company's operational or financial performance.
Positives
- The exercise of employee stock options indicates that the options were in-the-money, reflecting an increase in Stryker's stock price since the grant date.
- The transaction demonstrates a routine part of executive compensation, aligning management's interests with shareholder value creation over the long term.
Negatives
- A portion of the acquired shares was immediately sold, which reduces the direct beneficial ownership of the executive, although this is a common practice for tax purposes related to option exercises.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
StockSavvy.ai notes that insider transactions, particularly the exercise of long-held employee stock options followed by a sale to cover tax obligations, are a common and routine occurrence for executives in publicly traded companies across all industries, including the medical technology sector. These transactions typically reflect personal financial planning rather than a change in the executive's outlook on the company's prospects.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Spencer S. Stiles granted a Power of Attorney to several individuals (Austin Y. Ke, Jessica R. Kennedy, Jessica M. Herron, Garrett Packer, and Stephanie M. Swan) to act as his attorneys-in-fact for SEC filings, including Forms 3, 4, and 5. This allows for efficient and timely submission of required regulatory documents. | 08/21/2025 | This is a standard corporate governance practice to ensure compliance with SEC reporting requirements for insiders, streamlining the filing process and reducing administrative burden on the executive. |
Stakeholder Impact
- Shareholders: The transaction is a routine insider filing and is unlikely to have a significant direct impact on shareholders. It reflects a common aspect of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/10/2016 | Date employee stock options were granted to Spencer S. Stiles. |
| 08/21/2025 | Date the Power of Attorney was executed by Spencer S. Stiles. |
| 02/03/2026 | Date of the reported transactions (exercise of options and sale of shares). |
| 02/04/2026 | Date the Form 4 was signed by the attorney-in-fact. |
| 02/09/2026 | Expiration date of the employee stock options. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the exercise of stock options and a subsequent sale of shares for tax purposes. It does not provide new fundamental information about Stryker's business operations, financial health, or future prospects that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as this event is neutral to the company's investment thesis.
Keywords
Stryker, SYK, Insider Transaction, Form 4, Stock Options, Executive Compensation, Spencer S. Stiles, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.